Business Context and Reporting Period
This Form 6-K, filed on July 11, 2022, by Atlassian Corporation Plc, announces the convening of a Court Meeting and a General Meeting of shareholders scheduled for August 22, 2022. The primary purpose of these meetings is to seek shareholder approval for a proposed change of corporate domicile from the United Kingdom to the United States (the "U.S. Domestication").
Key Financial Metrics
The filing text does not provide specific financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and the proposed restructuring transaction.
Material Changes and Transaction Details
- Proposed Scheme: The U.S. Domestication will be effected via a court-approved scheme of arrangement under Part 26 of the UK Companies Act 2006.
- Share Exchange: Upon effectiveness, each existing Class A and Class B ordinary share of the UK company will be cancelled and exchanged for one share of common stock (par value $0.00001) of "New Atlassian," a newly incorporated Delaware corporation.
- Listing: The new Class A common stock is expected to be listed on the Nasdaq Global Select Market.
- Timeline: Subject to approvals and conditions, the Scheme is expected to become effective on September 30, 2022.
Guidance, Risks, and Contingencies
The filing includes a cautionary note regarding forward-looking statements and outlines several material risks and contingencies:
- Approval Requirements: The transaction is contingent upon shareholder approval, sanction by the High Court of Justice in England and Wales, and satisfaction of other closing conditions.
- Operational Risks: Potential negative impacts on relationships with vendors, customers, and employees; diversion of management time and resources; and possible delays or cancellation of other business opportunities.
- Financial and Tax Risks: Costs associated with the domestication may exceed estimates, and there is a risk of unanticipated adverse tax consequences.
- Market Risks: Potential adverse effects on the market price of shares if the Scheme fails to consummate.
Investor Verification Checklist
- Verify the outcome of the shareholder votes at the Court Meeting and General Meeting on August 22, 2022.
- Confirm the High Court of Justice in England and Wales sanctions the Scheme.
- Review the attached Proxy Statement (Exhibit 99.1) for detailed terms of the capital reduction and amendments to the articles of association.
- Monitor for any updates regarding the expected effective date of September 30, 2022, and the subsequent listing on Nasdaq.